Ye, Y., Liao, Y., Zhang, Y., Zhang, J., Luo, M., Yang, Q., . . . Wei, Q. (2025). KMT2D deficiency potentiates antitumor immunity and sensitizes immune checkpoint blockade in urologic cancers. Wiley. https://doi.org/10.1002/path.6481
Chicago Style (17th ed.) CitationYe, Yuedian, et al. KMT2D Deficiency Potentiates Antitumor Immunity and Sensitizes Immune Checkpoint Blockade in Urologic Cancers. Wiley, 2025. https://doi.org/10.1002/path.6481.
MLA (9th ed.) CitationYe, Yuedian, et al. KMT2D Deficiency Potentiates Antitumor Immunity and Sensitizes Immune Checkpoint Blockade in Urologic Cancers. Wiley, 2025. https://doi.org/10.1002/path.6481.
Warning: These citations may not always be 100% accurate.